Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2019
Jun 30, 2018
Jun 30, 2017
Jun 30, 2016
Total Revenue
655,407
684,563
633,341
542,493
Cost of Revenue
411,797
395,857
300,030
256,000
Gross Profit
243,610
288,706
333,311
286,493
Operating Expenses
Research Development
38,807
29,196
42,073
45,054
Selling General and Administrative
87,648
82,196
73,477
68,325
Non Recurring
--
--
--
7,166
Others
0
0
32,098
35,190
Total Operating Expenses
126,455
111,392
147,648
155,735
Operating Income or Loss
117,155
177,314
185,663
130,758
Income from Continuing Operations
Total Other Income/Expenses Net
(378,776)
(40,587)
(95,693)
(2,642)
Earnings Before Interest And Taxes
(261,621)
136,727
89,970
128,116
Interest Expense
84,624
85,634
89,420
65,937
Income Before Tax
(346,245)
51,093
550
62,179
Income Tax Expense
(74,138)
22,403
1,097
17,322
Minority Interest
--
0
0
408
Net Income From Continuing Ops
(272,107)
28,690
(547)
44,857
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
(34)
(75)
Net Income
(272,107)
28,690
(581)
44,782
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(272,107)
28,690
(581)
44,782